Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

HIV/AIDS

Studies from the United Kingdom and United States describe new findings in HIV/AIDS research

Study 1: Monocyte-derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses.

According to research from England, "The study tests the hypothesis that monocyte derived dendritic cells from HIV-1 infected individuals are normal and can restore impaired CD4 T-cell antigen specific responses. Monocyte derived dendritic cells were isolated from individuals at three different stages of HIV-1 infection with a wide spectrum of viral load and CD4 T-cell counts, and from healthy volunteers. The cell surface phenotype and allogeneic...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications